| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110
We generated transgenic mice that expressed hen egg-white lysozyme (HEL) under a class II MHC promoter. The A7 line expressed HEL with a point mutation in the Asp52 residue, the main anchor amino acid responsible for the selection of the chemically dominant family of peptides (52–60) by I-Ak molecules. Mice expressing HEL with Ala52 were completely unresponsive when immunized with the same protein, i.e., HEL A52. However, the same mice immunized with wild-type HEL elicited T cells that recognized a conformation of the 52–61 core sequence uniquely different between Asp52 and Ala52 containing peptides. Importantly, some T cells also recognized the HEL A52 peptide given exogenously but not the same peptide processed from HEL A52 protein. Thus, a core MHC anchor residue influences markedly the specificity of the T cells. We discuss the relevance of these findings to autoimmunity and vaccination with altered peptides.
This article has been cited by other articles:
|
|
 |
|
  H. Kobayashi, T. Nagato, K. Oikawa, K. Sato, S. Kimura, N. Aoki, R. Omiya, M. Tateno, and E. Celis Recognition of Prostate and Breast Tumor Cells by Helper T Lymphocytes Specific for a Prostate and Breast Tumor-Associated Antigen, TARP Clin. Cancer Res., May 15, 2005; 11(10): 3869 - 3878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Miley, I. Messaoudi, B. M. Metzner, Y. Wu, J. Nikolich-Zugich, and D. H. Fremont Structural Basis for the Restoration of TCR Recognition of an MHC Allelic Variant by Peptide Secondary Anchor Substitution J. Exp. Med., December 6, 2004; 200(11): 1445 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Gregers, B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke, and I. Sandlie MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation Int. Immunol., November 1, 2003; 15(11): 1291 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Consogno, S. Manici, V. Facchinetti, A. Bachi, J. Hammer, B. M. Conti-Fine, C. Rugarli, C. Traversari, and M. P. Protti Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3 Blood, February 1, 2003; 101(3): 1038 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Velazquez, I. Vidavsky, K. van der Drift, M. L. Gross, and E. R. Unanue Chemical Identification of a Low Abundance Lysozyme Peptide Family Bound to I-Ak Histocompatibility Molecules J. Biol. Chem., November 1, 2002; 277(45): 42514 - 42522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. DiPaolo and E. R. Unanue Cutting Edge: The Relative Distribution of T Cells Responding to Chemically Dominant or Minor Epitopes of Lysozyme Is Not Affected by CD40-CD40 Ligand and B7-CD28-CTLA-4 Costimulatory Pathways J. Immunol., September 15, 2002; 169(6): 2832 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Lawendowski, G. M. Giurleo, Y. Y. Huang, G. J. Franklin, J. M. Kaplan, B. L. Roberts, and C. A. Nicolette Solid-Phase Epitope Recovery: A High Throughput Method for Antigen Identification and Epitope Optimization J. Immunol., September 1, 2002; 169(5): 2414 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. DiPaolo and E. R. Unanue Cutting Edge: Chemical Dominance Does Not Relate to Immunodominance: Studies of the CD4+ T Cell Response to a Model Antigen J. Immunol., July 1, 2002; 169(1): 1 - 4. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Cirrito, Z. Pu, M. B. Deck, and E. R. Unanue Deamidation of Asparagine in a Major Histocompatibility Complex-Bound Peptide Affects T Cell Recognition but Does Not Explain Type B Reactivity J. Exp. Med., October 15, 2001; 194(8): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
